Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial 论文
2015The Lancet引用 1379
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsSynthesis of Tetrazole Derivatives